Automatically clustered newsroom coverage around one of the most active themes in the intellectual property ecosystem.
IIPLA reviews the patents implications of Patents, Silo Pharma Receives U.S, Patent Allowance, with practical notes for USA IP teams monitoring risk, enforcement, licensing, and portfolio strategy.
Genprex, Inc. announced that the Canadian Intellectual Property Office has issued a Notice of Allowance for a patent protecting the use of its REQORSA gene therapy in combination with PD-1 or PD-L1 antibodies to treat non-small cell and small cell lung cancers. This patent complements existing approvals in multiple co…
Heart Test Laboratories, Inc., through its exclusive licensee HeartSciences, has received a notice of allowance from the United States Patent and Trademark Office for a patent covering AI-based electrocardiogram (ECG) assessment of left ventricular and right ventricular dysfunction. This development reinforces HeartSc…
Subscribe to receive daily and weekly newsroom coverage aligned to this trend cluster and adjacent IP developments.